• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lithium in tardive dyskinesia.

作者信息

Simpson G M, Branchey M H, Lee J H, Voitashevsky A, Zoubok B

出版信息

Pharmakopsychiatr Neuropsychopharmakol. 1976 Mar;9(2):76-80. doi: 10.1055/s-0028-1094481.

DOI:10.1055/s-0028-1094481
PMID:790411
Abstract

A single blind trial and a placebo controlled double blind trial of lithium were carried out in elderly patients with tardive dyskinesia. In the pilot study, neuroleptics were continued: in the controlled trial, neuroleptics were discontinued. The results of both studies were essentially negative. Thus, the suppression effect of neuroleptics is much more dramatic than anything seen in the two studies. Several reasons for this were discussed namely, the severity and chronicity of the symptoms.

摘要

相似文献

1
Lithium in tardive dyskinesia.
Pharmakopsychiatr Neuropsychopharmakol. 1976 Mar;9(2):76-80. doi: 10.1055/s-0028-1094481.
2
Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
Pharmakopsychiatr Neuropsychopharmakol. 1975 Mar;8(2):51-6. doi: 10.1055/s-0028-1094443.
3
Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.二甲氨基乙醇、锂盐与安慰剂治疗迟发性运动障碍。一项双盲交叉研究。
Neuropsychobiology. 1978;4(3):140-9. doi: 10.1159/000117629.
4
[Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].[使用塞利洛尔进行β受体阻滞治疗服用抗精神病药物的迟发性运动障碍患者]
Wien Klin Wochenschr. 1986 Jun 13;98(12):388-92.
5
Bromocriptine in tardive dyskinesia.
Pharmacopsychiatria. 1982 Sep;15(5):161-3. doi: 10.1055/s-2007-1019530.
6
[Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
Cesk Psychiatr. 1983 Oct;79(5):339-45.
7
[Therapeutic measures in tardive dyskinesia].[迟发性运动障碍的治疗措施]
Fortschr Neurol Psychiatr. 1983 Jun;51(6):203-26. doi: 10.1055/s-2007-1002227.
8
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.利培酮治疗严重迟发性运动障碍:一项为期12周的随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2003 Nov;64(11):1342-8.
9
Failure of lithium treatment in established tardive dyskinesia.
Psychol Med. 1980 Aug;10(3):583-7. doi: 10.1017/s0033291700047498.
10
The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.可乐定在治疗抗精神病药所致迟发性运动障碍中的应用。
J Clin Psychopharmacol. 1986 Apr;6(2):88-92.

引用本文的文献

1
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.抗精神病药物所致迟发性运动障碍的其他治疗方法。
Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000208. doi: 10.1002/14651858.CD000208.pub2.
2
Lithium for schizophrenia.用于治疗精神分裂症的锂盐。
Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD003834. doi: 10.1002/14651858.CD003834.pub3.
3
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.中枢神经系统疾病的临床前和临床研究中锂的分子作用和治疗潜力。
Pharmacol Ther. 2010 Nov;128(2):281-304. doi: 10.1016/j.pharmthera.2010.07.006. Epub 2010 Aug 10.
4
Management of tardive dyskinesia: current update.迟发性运动障碍的管理:当前进展
Drugs. 1982 May;23(5):381-93. doi: 10.2165/00003495-198223050-00003.
5
Intra-patient variability in the measurement of tardive dyskinesia.
Psychopharmacology (Berl). 1982;76(3):269-72. doi: 10.1007/BF00432559.
6
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.锂在大鼠脑的多巴胺能通路中不与氟哌啶醇相互作用。
Psychopharmacology (Berl). 1984;82(4):330-4. doi: 10.1007/BF00427680.
7
What's new in the psychopharmacology of schizophrenia.精神分裂症精神药理学的新进展。
Bull N Y Acad Med. 1978 Oct;54(9):869-78.
8
A rating scale for tardive dyskinesia.迟发性运动障碍评定量表。
Psychopharmacology (Berl). 1979 Aug 8;64(2):171-9. doi: 10.1007/BF00496058.